A RARE CAUSE OF PITUITARY APOPLEXY: CABERGOLINE THERAPY

Pituitary apoplexy (PA) is a life-threatening clinical syndrome. Dopamine receptor agonists are the drugs of choice in the treatment of prolactinomas. The use of cabergoline is reported to cause an increased risk of PA, particularly in macroprolactinomas of cystic nature. In this report, we present...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Acta Endocrinol (Buchar)
Autores principales: Aydin, B., Aksu, O., Asci, H., Kayan, M., Korkmaz, H.
Formato: Artigo
Lenguaje:Inglês
Publicado: Acta Endocrinologica Foundation 2018
Materias:
Case Report
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6516607/
https://ncbi.nlm.nih.gov/pubmed/31149244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4183/aeb.2018.113
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares